John A. Merenich

1.2k total citations
39 papers, 934 citations indexed

About

John A. Merenich is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John A. Merenich has authored 39 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John A. Merenich's work include Lipoproteins and Cardiovascular Health (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). John A. Merenich is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). John A. Merenich collaborates with scholars based in United States and Qatar. John A. Merenich's co-authors include Kari L. Olson, Michael T. McDermott, Thomas Delate, Gerald S. Kidd, A. Arnold, Thomas F. Rehring, Harris W. Hollis, Marin H. Kollef, Karen McConnell and David L. McClure and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and The American Journal of Medicine.

In The Last Decade

John A. Merenich

38 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Merenich United States 19 264 260 183 139 130 39 934
Carole E. Aubert Switzerland 20 148 0.6× 333 1.3× 191 1.0× 132 0.9× 264 2.0× 92 1.2k
Marion Bertrand France 21 317 1.2× 95 0.4× 295 1.6× 126 0.9× 162 1.2× 51 1.4k
Colette B. Raymond Canada 16 275 1.0× 121 0.5× 125 0.7× 193 1.4× 53 0.4× 65 972
Daniala L. Weir Canada 12 104 0.4× 315 1.2× 210 1.1× 57 0.4× 132 1.0× 31 714
Amit D. Raval United States 21 169 0.6× 332 1.3× 156 0.9× 89 0.6× 363 2.8× 80 1.3k
Edward F. Tierney United States 14 160 0.6× 567 2.2× 134 0.7× 104 0.7× 289 2.2× 23 1.4k
Gerald M. Borok United States 11 212 0.8× 233 0.9× 200 1.1× 171 1.2× 415 3.2× 17 1.1k
Emily Atkins Australia 16 216 0.8× 224 0.9× 804 4.4× 128 0.9× 199 1.5× 69 1.4k
Fang Niu United States 14 124 0.5× 147 0.6× 91 0.5× 83 0.6× 61 0.5× 49 777
Nanette K. Wenger United States 18 264 1.0× 327 1.3× 862 4.7× 90 0.6× 205 1.6× 61 1.7k

Countries citing papers authored by John A. Merenich

Since Specialization
Citations

This map shows the geographic impact of John A. Merenich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Merenich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Merenich more than expected).

Fields of papers citing papers by John A. Merenich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Merenich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Merenich. The network helps show where John A. Merenich may publish in the future.

Co-authorship network of co-authors of John A. Merenich

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Merenich. A scholar is included among the top collaborators of John A. Merenich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Merenich. John A. Merenich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olson, Kari L., et al.. (2013). Ambulatory Treatment Gaps in Patients with Ischemic Stroke or Transient Ischemic Attack. The Permanente Journal. 17(3). 28–34. 1 indexed citations
2.
Delate, Thomas, et al.. (2010). Reduced Health Care Expenditures After Enrollment in a Collaborative Cardiac Care Service. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(11). 1127–1135. 11 indexed citations
3.
Olson, Kari L., et al.. (2010). The Risk for Significant Creatine Kinase Elevation with Statins. American Journal of Cardiovascular Drugs. 10(3). 187–192. 12 indexed citations
4.
Merenich, John A., et al.. (2007). Mortality Reduction Benefits of a Comprehensive Cardiac Care Program for Patients with Occlusive Coronary Artery Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(10). 1370–1378. 35 indexed citations
5.
McConnell, Karen, et al.. (2006). Coronary Artery Disease and Hypertension: Outcomes of a Pharmacist‐Managed Blood Pressure Program. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(9). 1333–1341. 23 indexed citations
6.
7.
Glasgow, Russell E., Paul A. Nutting, Deborah J. Toobert, et al.. (2006). Effects of a brief computer-assisted diabetes self-management intervention on dietary, biological and quality-of-life outcomes. Chronic Illness. 2(1). 27–38. 73 indexed citations
8.
Olson, Kari L., et al.. (2006). Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization. American Journal of Health-System Pharmacy. 64(1). 77–84. 26 indexed citations
9.
Rehring, Thomas F., et al.. (2005). Atherosclerotic risk factor control in patients with peripheral arterial disease. Journal of Vascular Surgery. 41(5). 816–822. 71 indexed citations
10.
Carroll, Nikki M., et al.. (2005). Low Myopathy Rates Associated with Statins as Monotherapy or Combination Therapy with Interacting Drugs in a Group Model Health Maintenance Organization. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(3). 345–351. 18 indexed citations
11.
Malone, Daniel C., Marsha A. Raebel, Julie A. Porter, et al.. (2005). Cost-Effectiveness of Sibutramine in the LOSE Weight Study:Evaluating the Role of Pharmacologic Weight-Loss Therapy Within a Weight Management Program. Journal of Managed Care Pharmacy. 11(6). 458–468. 9 indexed citations
12.
Porter, Julie A., Marsha A. Raebel, Douglas A. Conner, et al.. (2004). The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization.. PubMed. 10(6). 369–76. 27 indexed citations
13.
McConnell, Karen, et al.. (2003). Clinical Pharmacy Specialist Implementation of Lisinopril Therapy in Patients with Coronary Artery Disease and Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(12). 1564–1572. 10 indexed citations
14.
Merenich, John A., et al.. (2000). Optimizing treatment of dyslipidemia in patients with coronary artery disease in the managed-care environment (the Rocky Mountain Kaiser Permanente Experience). The American Journal of Cardiology. 85(3). 36–42. 30 indexed citations
15.
Rak, Kevin M., et al.. (1996). Correlation of Liver Density by Magnetic Resonance Imaging and Hepatic Iron Levels. Journal of Clinical Gastroenterology. 23(2). 113–117. 14 indexed citations
16.
Merenich, John A., et al.. (1995). Trial of Pentoxifylline for Diabetic Impotence. Diabetes Care. 18(3). 345–352. 6 indexed citations
17.
Merenich, John A., et al.. (1992). Lack of prostaglandin effect on sodium balance and hyperreninemia in adrenalectomized rats. Prostaglandins. 44(2). 111–117. 1 indexed citations
18.
Merenich, John A., et al.. (1990). Evidence of Endocrine Involvement Early in the Course of Human Immunodeficiency Virus Infection*. The Journal of Clinical Endocrinology & Metabolism. 70(3). 566–571. 115 indexed citations
19.
20.
Merenich, John A., Michael T. McDermott, & Gerald S. Kidd. (1989). Transient isolated thyrotropin deficiency in the postpartum period. The American Journal of Medicine. 86(3). 361–362. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole E. Aubert Breakdown of academic impact, for papers by Marion Bertrand Breakdown of academic impact, for papers by Colette B. Raymond Breakdown of academic impact, for papers by Daniala L. Weir Breakdown of academic impact, for papers by Amit D. Raval Breakdown of academic impact, for papers by Edward F. Tierney Breakdown of academic impact, for papers by Gerald M. Borok Breakdown of academic impact, for papers by Emily Atkins Breakdown of academic impact, for papers by Fang Niu Breakdown of academic impact, for papers by Nanette K. Wenger
Rankless by CCL
2026